ATE466086T1 - Expec-spezifische proteine, entsprechende gene und ihre verwendungen - Google Patents

Expec-spezifische proteine, entsprechende gene und ihre verwendungen

Info

Publication number
ATE466086T1
ATE466086T1 AT03724923T AT03724923T ATE466086T1 AT E466086 T1 ATE466086 T1 AT E466086T1 AT 03724923 T AT03724923 T AT 03724923T AT 03724923 T AT03724923 T AT 03724923T AT E466086 T1 ATE466086 T1 AT E466086T1
Authority
AT
Austria
Prior art keywords
polypeptides
expec
specific proteins
corresponding genes
conserved
Prior art date
Application number
AT03724923T
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis S A filed Critical Mutabilis S A
Application granted granted Critical
Publication of ATE466086T1 publication Critical patent/ATE466086T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03724923T 2002-03-06 2003-03-06 Expec-spezifische proteine, entsprechende gene und ihre verwendungen ATE466086T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290556A EP1342784A1 (de) 2002-03-06 2002-03-06 ExPEC-spezifische Proteine, entsprechende Gene und ihre Verwendungen
PCT/EP2003/002925 WO2003074553A2 (en) 2002-03-06 2003-03-06 Expec-specific proteins, genes encoding them and uses thereof

Publications (1)

Publication Number Publication Date
ATE466086T1 true ATE466086T1 (de) 2010-05-15

Family

ID=27741246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724923T ATE466086T1 (de) 2002-03-06 2003-03-06 Expec-spezifische proteine, entsprechende gene und ihre verwendungen

Country Status (8)

Country Link
US (2) US20060188514A1 (de)
EP (3) EP1342784A1 (de)
JP (2) JP2006502696A (de)
AT (1) ATE466086T1 (de)
AU (2) AU2003227537A1 (de)
CA (1) CA2478277A1 (de)
DE (1) DE60332324D1 (de)
WO (1) WO2003074553A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
EP1570856A3 (de) * 2004-02-26 2005-10-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Eine Impfstoffzusammensetzung, die ein Immunoadjuvants-Verbindung bestehend aus einem RHO GTPase-Aktivator.
EP1580195A1 (de) * 2004-03-26 2005-09-28 Mutabilis SA Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie
SI2351772T1 (sl) 2005-02-18 2016-11-30 Glaxosmithkline Biologicals Sa Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
JP2008530245A (ja) 2005-02-18 2008-08-07 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 尿路病原性菌株由来の抗原
EP2586790A3 (de) * 2006-08-16 2013-08-14 Novartis AG Immunogene von uropathogenen Escherichia coli
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
SI2464658T1 (sl) 2009-07-16 2015-02-27 Novartis Ag Detoksificirani imunogeni escherichie coli
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
KR102790878B1 (ko) 2018-08-09 2025-04-02 앤타바이오 에스에이에스 세린 베타-락타마제의 억제제로서 다이아자바이사이클로옥타논

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ES2076895B1 (es) * 1994-02-04 1996-08-16 Ind Farma Especial Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
EP0817647A4 (de) * 1995-03-24 2002-10-30 Promega Corp Behandlung von verotoxin-produzierenden escherichia coli
US6365723B1 (en) * 1998-12-04 2002-04-02 Wisconsin Alumni Research Foundation Sequences of E. coli O157
CA2402602A1 (en) * 2000-03-10 2001-09-13 Edouard Bingen Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides

Also Published As

Publication number Publication date
US20060188514A1 (en) 2006-08-24
AU2010201045A1 (en) 2010-04-08
EP2253707A3 (de) 2011-03-02
US20100260789A1 (en) 2010-10-14
CA2478277A1 (en) 2003-09-12
DE60332324D1 (de) 2010-06-10
AU2003227537A2 (en) 2003-09-16
EP1481062A2 (de) 2004-12-01
WO2003074553A3 (en) 2004-03-25
WO2003074553A2 (en) 2003-09-12
JP2006502696A (ja) 2006-01-26
EP1342784A1 (de) 2003-09-10
AU2003227537A1 (en) 2003-09-16
JP2010189411A (ja) 2010-09-02
EP2253707A2 (de) 2010-11-24
HK1073478A1 (en) 2005-10-07
EP1481062B1 (de) 2010-04-28

Similar Documents

Publication Publication Date Title
DE60217320D1 (de) Gonokokkenproteine und nukleinsäuren
ATE376591T1 (de) Neisseria meningitidis antigene und zusammenstellungen
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
NO20034244D0 (no) Mikrobielt fôr for akvakultur og landbruk
ATA1302001A (de) Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
DE60140259D1 (de) Antikörper gegen tnf, zusammensetzungen, verfahren und verwendungen
DE60332324D1 (de) Expec-spezifische proteine, entsprechende gene und ihre verwendungen
DE60035337D1 (de) Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoide Tumorzellen, herbeiführen oder bewirken
WO2002097048A3 (en) ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
WO2003038041A3 (en) Il-4 mutein proteins, antibodies, compositions, methods and uses
DE60322727D1 (de) Rückgefaltetes Membranprotein in monodisperser Form
ATE386541T1 (de) Neisseria impfstoffzusammensetzungen und methoden
ATE382056T1 (de) Virulenz gene, proteine, und ihre verwendung
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
EP1608672A4 (de) Peptide, polypeptide und proteine mit reduzierter immunogenität und verfahren zu deren herstellung
ATE349530T1 (de) Nukleinsäuren und proteine des mph3 gens aus mycoplasma hypopneumoniae und deren verwendung
BR0110867A (pt) Toxinas
DE60213827D1 (de) Antikörper gegen Caspase-8, ihre Herstellung und Verwendung
WO2001092524A3 (en) Myosin-like gene expressed in human heart and muscle
ATE512981T1 (de) Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
DE602004019696D1 (de) Die multiple resistenz von pflanzen gegen phytopathogene und schädlinge induzierende proteine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties